
Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Activity
2025-12-19 12:00:08Divis Laboratories has experienced a significant surge in open interest within its derivatives segment, reflecting heightened market participation and evolving positioning among investors. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased attention from market participants in the Pharmaceuticals & Biotechnology space.
Read More
Divis Laboratories Sees Heavy Put Option Activity Ahead of December Expiry
2025-12-19 12:00:07Divis Laboratories Ltd has emerged as the most active stock in put options trading as the December 2025 expiry approaches, signalling notable investor positioning in the pharmaceuticals sector. The surge in put contracts at the 6,500 strike price highlights a cautious stance amid recent price movements and market dynamics.
Read More
Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Momentum
2025-12-19 11:00:08Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, coinciding with a positive price trajectory and increased investor participation. This development highlights evolving market positioning and potential directional bets in the pharmaceutical sector.
Read More
Divis Laboratories Sees Robust Trading Activity Amid Pharmaceutical Sector Momentum
2025-12-19 10:00:16Divis Laboratories has emerged as one of the most actively traded stocks by value in the Indian equity market, reflecting heightened investor interest and strong liquidity within the Pharmaceuticals & Biotechnology sector. The stock's recent trading session demonstrated notable price movement and volume dynamics, underscoring its significance among large-cap pharmaceutical companies.
Read More
Divis Laboratories Sees Robust Call Option Activity Amid Bullish Market Sentiment
2025-12-19 10:00:12Divis Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has attracted significant attention in the derivatives market with heavy call option trading ahead of the December expiry. The stock’s underlying value, combined with active strike prices and rising investor participation, signals a bullish positioning among market participants as it outperforms its sector and broader indices.
Read More
Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
2025-12-19 10:00:08Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, reflecting heightened market activity and evolving investor positioning. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased interest from market participants in the pharmaceutical and biotechnology space.
Read More
Divis Laboratories Hits Intraday High with Strong 3.3% Surge
2025-12-19 09:32:23Divis Laboratories demonstrated robust intraday performance on 19 Dec 2025, touching a high of Rs 6,592, reflecting a 3.31% rise during the trading session. The stock outpaced its sector and broader market indices, supported by notable volatility and sustained momentum across multiple moving averages.
Read More
Divis Laboratories Hits Intraday High with Strong 3.17% Surge
2025-12-11 12:21:11Divis Laboratories demonstrated robust intraday performance on 11 Dec 2025, reaching a day’s high of Rs 6,491.9, reflecting a 3.17% rise. The stock outpaced its sector and broader market indices, supported by sustained buying momentum and favourable technical indicators.
Read More
Divis Laboratories Hits Intraday Low Amid Price Pressure and Market Headwinds
2025-12-08 15:01:37Shares of Divis Laboratories experienced a notable decline today, touching an intraday low of Rs 6,275.45 as the stock faced downward pressure amid broader market weakness and sector-specific dynamics.
Read MoreDivi's Laboratories Limited - Other General Purpose
03-Dec-2019 | Source : NSEDivi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
18-Nov-2019 | Source : NSEDivi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Divi's Laboratories Limited - Updates
15-Nov-2019 | Source : NSEDivi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.
Corporate Actions
No Upcoming Board Meetings
Divis Laboratories Ltd has declared 1500% dividend, ex-date: 25 Jul 25
Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07
Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15
No Rights history available






